Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cheifetz

Showing results (31-40 of 263) with videos related to

Pageof 27
Sort By:
Current Treatment Options in Gastroenterology|May 26, 2005
Infliximab: Use in Inflammatory Bowel DiseaseWin J Travassos, Adam S Cheifetz
The Journal of Biological Chemistry|July 25, 1986
Cellular distribution of type I and type II receptors for transforming growth factor-betaS Cheifetz, B Like, J Massagué
Inflammatory Bowel Diseases|September 26, 2008
How often is a diagnosis of ulcerative colitis changed to Crohn's disease and vice versa?Alan C Moss, Adam S Cheifetz
Gastroenterology|May 7, 2022
PUCCINI: Safety of Anti-TNF in the Perioperative SettingNeil H Hyman, Adam S Cheifetz
Expert Review of Gastroenterology & Hepatology|August 14, 2009
Management of acute severe ulcerative colitisGlen A Doherty, Adam S Cheifetz
Gastroenterology & Hepatology|September 1, 2018
The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel DiseaseSteven C Lin, Adam S Cheifetz
Digestive Diseases and Sciences|May 2, 2026
Is It Safe? Long-Term Anti-TNF Therapy - Less to Fear Than We ThinkDavide De Marco, Adam S Cheifetz
Inflammatory Bowel Diseases|May 23, 2009
Targeting TNF in postoperative recurrence of Crohn's disease: can we extinguish the fire before it starts?Glen A Doherty, Adam S Cheifetz
Journal of Clinical Gastroenterology|September 21, 2007
Reducing the torment of diarrhea: tormentil for active ulcerative colitisAlan C Moss, Adam S Cheifetz
Gastrointestinal Endoscopy|February 24, 2020
ResponseJoseph D Feuerstein, Adam S Cheifetz
Pageof 27

Showing results (31-40 of 263) with videos related to

Sort By:
Pageof 27
Current Treatment Options in Gastroenterology|May 26, 2005
Infliximab: Use in Inflammatory Bowel DiseaseWin J Travassos, Adam S Cheifetz
The Journal of Biological Chemistry|July 25, 1986
Cellular distribution of type I and type II receptors for transforming growth factor-betaS Cheifetz, B Like, J Massagué
Inflammatory Bowel Diseases|September 26, 2008
How often is a diagnosis of ulcerative colitis changed to Crohn's disease and vice versa?Alan C Moss, Adam S Cheifetz
Gastroenterology|May 7, 2022
PUCCINI: Safety of Anti-TNF in the Perioperative SettingNeil H Hyman, Adam S Cheifetz
Expert Review of Gastroenterology & Hepatology|August 14, 2009
Management of acute severe ulcerative colitisGlen A Doherty, Adam S Cheifetz
Gastroenterology & Hepatology|September 1, 2018
The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel DiseaseSteven C Lin, Adam S Cheifetz
Digestive Diseases and Sciences|May 2, 2026
Is It Safe? Long-Term Anti-TNF Therapy - Less to Fear Than We ThinkDavide De Marco, Adam S Cheifetz
Inflammatory Bowel Diseases|May 23, 2009
Targeting TNF in postoperative recurrence of Crohn's disease: can we extinguish the fire before it starts?Glen A Doherty, Adam S Cheifetz
Journal of Clinical Gastroenterology|September 21, 2007
Reducing the torment of diarrhea: tormentil for active ulcerative colitisAlan C Moss, Adam S Cheifetz
Gastrointestinal Endoscopy|February 24, 2020
ResponseJoseph D Feuerstein, Adam S Cheifetz
Pageof 27